For individuals unable to afford newer PCSK9 inhibitors or bempedoic acid, statins remain a viable option, with pitavastatin and rosuvastatin potentially preferred due to a better side effect profile.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.